Leading Company Profile
✉ Email this page to a colleague
What is the competitive landscape for LEADING, and what generic and branded alternatives to LEADING drugs are available?
LEADING has twenty approved drugs.
Drugs and US Patents for Leading
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Leading | HYDROXYUREA | hydroxyurea | CAPSULE;ORAL | 213438-001 | Apr 8, 2020 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ||||
Leading | METOLAZONE | metolazone | TABLET;ORAL | 218606-002 | Apr 17, 2024 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ||||
Leading | METOLAZONE | metolazone | TABLET;ORAL | 218606-001 | Apr 17, 2024 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ||||
Leading | DIPHENOXYLATE HYDROCHLORIDE AND ATROPINE SULFATE | atropine sulfate; diphenoxylate hydrochloride | TABLET;ORAL | 213413-001 | Feb 20, 2020 | AA | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ||||
Leading | HYDROCHLOROTHIAZIDE | hydrochlorothiazide | TABLET;ORAL | 040702-003 | May 10, 2017 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Similar Applicant Names
Here is a list of applicants with similar names.